Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis

Cancer Epidemiology

Volumn 38, Issue 4, 2014, Pages 329-338

  Caini, Saverio ^a   Gandini, Sara ^b   Dudas, Maria ^c   Bremer, Viviane ^d   Severi, Ettore ^e   Gherasim, Alin ^f  

^a Unit of Molecular and Nutritional Epidemiology Institute for Cancer Research and Prevention (ISPO)   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^d ROBERT KOCH INSTITUTE   (Germany)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Gonorrhoea; Meta analysis; Prostate cancer; Review; Sexually transmitted diseases

Indexed keywords

BIBLIOGRAPHIC DATABASE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CHLAMYDIA TRACHOMATIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; GONORRHEA; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 8; INFECTION PREVENTION; MEDICAL LITERATURE; META ANALYSIS (TOPIC); MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLISHING; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; COMPLICATION; MALE; META ANALYSIS; PROSTATIC NEOPLASMS;

HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES;

EID: 84904561115     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.06.002     Document Type: Review

References (83)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Huncharek M., Haddock K.S., Reid R., Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010, 100(4):693-701.
3. Discacciati A., Orsini N., Wolk A. Body mass index and incidence of localized and advanced prostate cancer - a dose-response meta-analysis of prospective studies. Ann Oncol 2012, 23(7):1665-1671.
4. Liu Y., Hu F., Li D., Wang F., Zhu L., Chen W., et al. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 2011, 60(5):1029-1044.
5. Dunne E.F., Nielson C.M., Stone K.M., Markowitz L.E., Giuliano A.R. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006, 194(8):1044-1057.
6. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008, 86(10):805-812.
7. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl. 10):K1-K16.
8. Chaturvedi A.K. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010, 46(4 Suppl.):S20-S26.
9. World Health Organization (WHO) Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates 2011, World Health Organization, Geneva, Available from: http://whqlibdoc.who.int/publications/2011/9789241502450_eng.pdf [accessed 09.03.13].
10. European Centre for Disease Prevention and Control Sexually transmitted infections in Europe 2011 2013, ECDC, Stockholm.
11. Centers for Disease Control and Prevention Sexually transmitted disease surveillance 2010 2011, U.S. Department of Health and Human Services, Atlanta.
12. Graham S., Guy R.J., Donovan B., McManus H., Su J.Y., El-Hayek C., et al. Epidemiology of chlamydia and gonorrhoea among Indigenous and non-Indigenous Australians, 2000-2009. Med J Aust 2012, 197(11):642-646.
13. Fang L., Oliver A., Jayaraman G.C., Wong T. Trends in age disparities between younger and middle-age adults among reported rates of chlamydia, gonorrhea, and infectious syphilis infections in Canada: findings from 1997 to 2007. Sex Transm Dis 2010, 37(1):18-25.
14. Velicko I., Unemo M. Recent trends in gonorrhoea and syphilis epidemiology in Sweden: 2007 to 2011. Euro Surveill 2012, 17(29).
15. Savage E.J., Marsh K., Duffell S., Ison C.A., Zaman A., Hughes G. Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Euro Surveill 2012, 17(29).
16. Van de Laar M., Spiteri G. Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. Euro Surveill 2012, 17(29).
17. Ravich A., Ravich R.A. Prophylaxis of cancer of the prostate, penis and cervix by circumcision. N Y State J Med 1951, 51(12):1519-1520.
18. Sutcliffe S. Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future Oncol 2010, 6(8):1289-1311.
19. Lin Y., Mao Q., Zheng X., Yang K., Chen H., Zhou C., et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis. Ir J Med Sci 2011, 180(2):497-503.
20. Taylor M.L., Mainous A.G., Wells B.J. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med 2005, 37(7):506-512.
21. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987, 9:1-30.
22. van Houwelingen H.C., Arends L.R., Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002, 21(4):589-624.
23. Macaskill P., Walter S.D., Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001, 20(4):641-654.
24. Steele R., Lees R.E., Kraus A.S., Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis 1971, 24(1):29-37.
25. Wynder E.L., Mabuchi K., Whitmore W.F. Epidemiology of cancer of the prostate. Cancer 1971, 28(2):344-360.
26. Krain L.S. Epidemiologic variables in prostatic cancer. Geriatrics 1973, 28(5):93-98.
27. Krain L.S. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974, 3(1):154-159.
28. Heshmat M.Y., Kovi J., Herson J., Jones G.W., Jackson M.A. Epidemiologic association between gonorrhea and prostatic carcinoma. Urology 1975, 6(4):457-460.
29. Herbert J.T., Birkhoff J.D., Feorino P.M., Caldwell G.G. Herpes simplex virus type 2 and cancer of the prostate. J Urol 1976, 116(5):611-612.
30. Baker L.H., Mebust W.K., Chin T.D., Chapman A.L., Hinthorn D., Twole D. The relationship of herpesvirus to carcinoma of the prostate. J Urol 1981, 125(3):370-374.
31. Lüleci G., Sakizli M., Günalp A., Erkan I., Remzi D. Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix. J Surg Oncol 1981, 16(4):327-331.
32. Ross R.K., Paganini-Hill A., Henderson B.E. The etiology of prostate cancer: what does the epidemiology suggest?. Prostate 1983, 4(4):333-344.
33. Lees R.E., Steele R., Wardle D. Arsenic, syphilis, and cancer of the prostate. J Epidemiol Community Health 1985, 39(3):227-230.
34. Mishina T., Watanabe H., Araki H., Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 1985, 6(4):423-436.
35. Checkoway H., DiFerdinando G., Hulka B.S., Mickey D.D. Medical, life-style, and occupational risk factors for prostate cancer. Prostate 1987, 10(1):79-88.
36. Mandel J.S., Schuman L.M. Sexual factors and prostatic cancer: results from a case-control study. J Gerontol 1987, 42(3):259-264.
37. Ross R.K., Shimizu H., Paganini-Hill A., Honda G., Henderson B.E. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987, 78(5):869-874.
38. Honda G.D., Bernstein L., Ross R.K., Greenland S., Gerkins V., Henderson B.E. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1988, 57(3):326-331.
39. Oishi K., Okada K., Yoshida O., Yamabe H., Ohno Y., Hayes R.B., et al. Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors. Prostate 1989, 14(2):117-122.
40. Oishi K., Okada K., Yoshida O., Yamabe H., Ohno Y., Hayes R.B., et al. A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors. Prostate 1990, 17(4):269-279.
41. Hiatt R.A., Armstrong M.A., Klatsky A.L., Sidney S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 1994, 5(1):66-72.
42. Michalek A.M., Mahoney M.C., McLaughlin C.C., Murphy D., Metzger B.B. Historical and contemporary correlates of syphilis and cancer. Int J Epidemiol 1994, 23(2):381-385.
43. Ewings P., Bowie C. A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer 1996, 74(4):661-666.
44. Ilić M., Vlajinac H., Marinković J. Case-control study of risk factors for prostate cancer. Br J Cancer 1996, 74(10):1682-1686.
45. Dillner J., Knekt P., Boman J., Lehtinen M., Af Geijersstam V., Sapp M., et al. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 1998, 75(4):564-567.
46. Hsieh C.C., Thanos A., Mitropoulos D., Deliveliotis C., Mantzoros C.S., Trichopoulos D. Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 1999, 80(5):699-703.
47. Hayes R.B., Pottern L.M., Strickler H., Rabkin C., Pope V., Swanson G.M., et al. Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 2000, 82(3):718-725.
48. Rosenblatt K.A., Wicklund K.G., Stanford J.L. Sexual factors and the risk of prostate cancer. Am J Epidemiol 2001, 153(12):1152-1158.
49. Hoffman L.J., Bunker C.H., Pellett P.E., Trump D.L., Patrick A.L., Dollard S.C., et al. Elevated seroprevalence of Human Herpesvirus 8 among men with prostate cancer. J Infect Dis 2004, 189(1):15-20.
50. Lightfoot N., Conlon M., Kreiger N., Sass-Kortsak A., Purdham J., Darlington G. Medical history, sexual, and maturational factors and prostate cancer risk. Ann Epidemiol 2004, 14(9):655-662.
51. Sanderson M., Coker A.L., Logan P., Zheng W., Fadden M.K. Lifestyle and prostate cancer among older African-American and Caucasian men in South Carolina. Cancer Causes Control 2004, 15(7):647-655.
52. Anttila T., Tenkanen L., Lumme S., Leinonen M., Gislefoss R.E., Hallmans G., et al. Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(2):385-389.
53. Fernández L., Galán Y., Jiménez R., Gutiérrez A., Guerra M., Pereda C., et al. Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba. Int J Epidemiol 2005, 34(1):193-197.
54. Korodi Z., Wang X., Tedeschi R., Knekt P., Dillner J. No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: a nested case-control study. J Infect Dis 2005, 191(12):2008-2011.
55. Patel D.A., Bock C.H., Schwartz K., Wenzlaff A.S., Demers R.Y., Severson R.K. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case-control study in Wayne County, Michigan. Cancer Causes Control 2005, 16(3):263-273.
56. Pelucchi C., Talamini R., Negri E., Franceschi S., La Vecchia C. Genital and urinary tract diseases and prostate cancer risk. Eur J Cancer Prev 2006, 15(3):254-257.
57. Sarma A.V., McLaughlin J.C., Wallner L.P., Dunn R.L., Cooney K.A., Schottenfeld D., et al. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol 2006, 176(3):1108-1113.
58. Sutcliffe S., Giovannucci E., De Marzo A.M., Leitzmann M.F., Willett W.C., Platz E.A. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006, 15(11):2160-2166.
59. Sutcliffe S., Giovannucci E., Alderete J.F., Chang T.H., Gaydos C.A., Zenilman J.M., et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006, 15(5):939-945.
60. Jenkins F.J., Hayes R.B., Jackson A., Pizza G., Mbisa G., Whitby D., et al. Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis 2007, 196(2):208-211.
61. Pourmand G., Salem S., Mehrsai A., Lotfi M., Amirzargar M.A., Mazdak H., et al. The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev 2007, 8(3):422-428.
62. Sutcliffe S., Giovannucci E., Gaydos C.A., Viscidi R.P., Jenkins F.J., Zenilman J.M., et al. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2007, 16(8):1573-1580.
63. Huang W.Y., Hayes R., Pfeiffer R., Viscidi R.P., Lee F.K., Wang Y.F., et al. Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008, 17(9):2374-2381.
64. Dennis L.K., Coughlin J.A., McKinnon B.C., Wells T.S., Gaydos C.A., Hamsikova E., et al. Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomarkers Prev 2009, 18(10):2665-2671.
65. Dimitropoulou P., Lophatananon A., Easton D., Pocock R., Dearnaley D.P., Guy M., et al. Sexual activity and prostate cancer risk in men diagnosed at a younger age. BJU Int 2009, 103(2):178-185.
66. Stark J.R., Judson G., Alderete J.F., Mundodi V., Kucknoor A.S., Giovannucci E.L., et al. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst 2009, 101(20):1406-1411.
67. Sutcliffe S., Alderete J.F., Till C., Goodman P.J., Hsing A.W., Zenilman J.M., et al. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int J Cancer 2009, 124(9):2082-2087.
68. Cheng I., Witte J.S., Jacobsen S.J., Haque R., Quinn V.P., Quesenberry C.P., et al. Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS ONE 2010, 5(1):e8736.
69. Ahmadi H., Allameh F., Baradaran N., Montaser-Kouhsari L., Bazargan-Hejazi S., Salem S., et al. Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer. J Sex Med 2011, 8(3):905-913.
70. Hrbacek J., Urban M., Hamsikova E., Tachezy R., Eis V., Brabec M., et al. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer 2011, 11:53.
71. Fisher D.G., Reynolds G.L., Creekmur B., Johnson M.E., Deaugustine N. Reliability and criterion-related validity of self-report of syphilis. Sex Transm Dis 2007, 34(6):389-391.
72. Mishori R., McClaskey E.L., WinklerPrins V.J. Chlamydia trachomatis infections: screening, diagnosis, and management. Am Fam Physician 2012, 86(12):1127-1132.
73. Telesca D., Etzioni R., Gulati R. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics 2008, 64(1):10-19.
74. Giovannucci E., Liu Y., Platz E.A., Stampfer M.J., Willett W.C. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007, 121(7):1571-1578.
75. National Program of Cancer Registries United States cancer statistics: 1999-2007 cancer incidence and mortality data 2012, Centers for Disease Control and Prevention, Atlanta, GA, Available from: http://apps.nccd.cdc.gov/uscs/ [accessed 04.03.13].
76. Kicinski M., Vangronsveld J., Nawrot T.S. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis. PLoS ONE 2011, 6(10):e21730.
77. Alvarez-Cubero M.J., Saiz M., Martinez-Gonzalez L.J., Alvarez J.C., Lorente J.A., Cozar J.M. Genetic analysis of the principal genes related to prostate cancer: a review. Urol Oncol 2012, (12):S1078-S1439.
78. Gann P.H. Risk factors for prostate cancer. Rev Urol 2002, 4(Suppl. 5):S3-S10.
79. Parkin D.M., Boyd L., Walker L.C. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011, 105(Suppl. 2):S77-S81.
80. Ilic D., Neuberger M.M., Djulbegovic M., Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev 2013, 1:CD004720.
81. Schröder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Melen V., et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012, 366(11):981-990.
82. Moyer V.A., U.S.Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 157(2):120-134.
83. Mitra A.V., Bancroft E.K., Barbachano Y., Page E.C., Foster C.S., Jameson C., et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int 2011, 107(1):28-39.